Of the 25 antiretroviral drugs available in the market, only 16 are allowed for prescription in the pediatric patients. The antiretroviral, pertaining to the first three families, used for two decades, remain valid and are important components of antiretroviral therapy in naive children. We describe doses, presentations and current associations for these drugs in children, and also discuss new co-formulations that will reduce the number of doses, improve tolerance and therefore achieve better adherence of pediatric patients.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.4067/s0716-10182010000600012 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!